In response to the FDA, Bishop Michael Burbidge, who became the USCCB pro-life chair in November, warned of the dangers to mothers and their unborn children and reaffirmed the Church’s position on life.
In response to the FDA, Bishop Michael Burbidge, who became the USCCB pro-life chair in November, warned of the dangers to mothers and their unborn children and reaffirmed the Church’s position on life.